|
1
|
Ishibashi K, Hara S and Kondo S: Aquaporin
water channels in mammals. Clin Exp Nephrol. 13:107–117. 2009.
View Article : Google Scholar
|
|
2
|
Mukhopadhyay R, Bhattacharjee H and Rosen
BP: Aquaglyceroporins: Generalized metalloid channels. Biochim
Biophys Acta. 1840:1583–1591. 2014. View Article : Google Scholar :
|
|
3
|
Papadopoulos MC and Verkman AS:
Aquaporin-4 gene disruption in mice reduces brain swelling and
mortality in pneumococcal meningitis. J Biol Chem. 280:13906–13912.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Calamita G, Gena P, Ferri D, Rosito A,
Rojek A, Nielsen S, Marinelli RA, Frühbeck G and Svelto M:
Biophysical assessment of aquaporin-9 as principal facilitative
pathway in mouse liver import of glucogenetic glycerol. Biol Cell.
104:342–351. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Amiry-Moghaddam M, Williamson A, Palomba
M, Eid T, de Lanerolle NC, Nagelhus EA, Adams ME, Froehner SC, Agre
P and Ottersen OP: Delayed K+ clearance associated with aquaporin-4
mislocalization: Phenotypic defects in brains of
alpha-syntrophin-null mice. Proc Natl Acad Sci USA.
100:13615–13620. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hara-Chikuma M and Verkman AS: Aquaporin-1
facilitates epithelial cell migration in kidney proximal tubule. J
Am Soc Nephrol. 17:39–45. 2006. View Article : Google Scholar
|
|
7
|
Rodríguez A, Catalán V, Gómez-Ambrosi J,
García-Navarro S, Rotellar F, Valentí V, Silva C, Gil MJ, Salvador
J, Burrell MA, et al: Insulin- and leptin-mediated control of
aquaglyceroporins in human adipocytes and hepatocytes is mediated
via the PI3K/Akt/mTOR signaling cascade. J Clin Endocrinol Metab.
96:E586–E597. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Maeda N: Implications of aquaglyceroporins
7 and 9 in glycerol metabolism and metabolic syndrome. Mol Aspects
Med. 33:665–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rodríguez A, Catalán V, Gómez-Ambrosi J
and Frühbeck G: Aquaglyceroporins serve as metabolic gateways in
adiposity and insulin resistance control. Cell Cycle. 10:1548–1556.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ribatti D, Ranieri G, Annese T and Nico B:
Aquaporins in cancer. Biochim Biophys Acta. 1840:1550–1553. 2014.
View Article : Google Scholar
|
|
11
|
Kusayama M, Wada K, Nagata M, Ishimoto S,
Takahashi H, Yoneda M, Nakajima A, Okura M, Kogo M and Kamisaki Y:
Critical role of aquaporin 3 on growth of human esophageal and oral
squamous cell carcinoma. Cancer Sci. 102:1128–1136. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tan G, Sun SQ and Yuan DL: Expression of
the water channel protein aquaporin-9 in human astrocytic tumours:
Correlation with pathological grade. J Int Med Res. 36:777–782.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Venook AP, Papandreou C, Furuse J and de
Guevara LL: The incidence and epidemiology of hepatocellular
carcinoma: A global and regional perspective. Oncologist. 15(Suppl
4): S5–S13. 2010. View Article : Google Scholar
|
|
14
|
Guo X, Sun T, Yang M, Li Z, Li Z and Gao
Y: Prognostic value of combined aquaporin 3 and aquaporin 5
overexpression in hepatocellular carcinoma. Biomed Res Int.
2013:2065252013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jablonski EM, Mattocks MA, Sokolov E,
Koniaris LG, Hughes FM Jr, Fausto N, Pierce RH and McKillop IH:
Decreased aquaporin expression leads to increased resistance to
apoptosis in hepatocellular carcinoma. Cancer Lett. 250:36–46.
2007. View Article : Google Scholar
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (-Delta Delta C (T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Verkman AS, Anderson MO and Papadopoulos
MC: Aquaporins: Important but elusive drug targets. Nat Rev Drug
Discov. 13:259–277. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li A, Lu D, Zhang Y, Li J, Fang Y, Li F
and Sun J: Critical role of aquaporin-3 in epidermal growth
factor-induced migration of colorectal carcinoma cells and its
clinical significance. Oncol Rep. 29:535–540. 2013.
|
|
19
|
Chen J, Wang T, Zhou YC, Gao F, Zhang ZH,
Xu H, Wang SL and Shen LZ: Aquaporin 3 promotes
epithelial-mesenchymal transition in gastric cancer. J Exp Clin
Cancer Res. 33:382014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen R, Shi Y, Amiduo R, Tuokan T and
Suzuk L: Expression and prognostic value of aquaporin 1, 3 in
cervical carcinoma in women of Uygur ethnicity from Xinjiang,
China. PLoS One. 9:e985762014. View Article : Google Scholar
|
|
21
|
Jablonski EM, Mattocks MA, Sokolov E,
Koniaris LG, Hughes FM Jr, Fausto N, Pierce RH and McKillop IH:
Decreased aquaporin expression leads to increased resistance to
apoptosis in hepatocellular carcinoma. Cancer Lett. 250:36–46.
2007. View Article : Google Scholar
|
|
22
|
Rubenwolf PC, Otto W, Denzinger S,
Hofstädter F, Wieland W and Georgopoulos NT: Expression of
aquaporin water channels in human urothelial carcinoma: Correlation
of AQP3 expression with tumour grade and stage. World J Urol.
32:991–997. 2014. View Article : Google Scholar
|
|
23
|
Nihei K, Koyama Y, Tani T, Yaoita E,
Ohshiro K, Adhikary LP, Kurosaki I, Shirai Y, Hatakeyama K and
Yamamoto T: Immunolocalization of aquaporin-9 in rat hepatocytes
and Leydig cells. Arch Histol Cytol. 64:81–88. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Elkjaer M, Vajda Z, Nejsum LN, Kwon T,
Jensen UB, Amiry-Moghaddam M, Frøkiaer J and Nielsen S:
Immunolocalization of AQP9 in liver, epididymis, testis, spleen,
and brain. Biochem Biophys Res Commun. 276:1118–1128. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu Y, Promeneur D, Rojek A, Kumar N,
Frøkiaer J, Nielsen S, King LS, Agre P and Carbrey JM: Aquaporin 9
is the major pathway for glycerol uptake by mouse erythrocytes,
with implications for malarial virulence. Proc Natl Acad Sci USA.
104:12560–12564. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xie H, Liu F, Liu L, Dan J, Luo Y, Yi Y,
Chen X and Li J: Protective role of AQP3 in UVA-induced NHSFs
apoptosis via Bcl2 up-regulation. Arch Dermatol Res. 305:397–406.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Trigueros-Motos L, Pérez-Torras S, Casado
FJ, Molina-Arcas M and Pastor-Anglada M: Aquaporin 3 (AQP3)
participates in the cytotoxic response to nucleoside-derived drugs.
BMC Cancer. 12:4342012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shen FX, Gu X, Pan W, Li WP, Li W, Ye J,
Yang LJ, Gu XJ and Ni LS: Over-expression of AQP7 contributes to
improve insulin resistance in adipocytes. Exp Cell Res.
318:2377–2384. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen J, Wang T, Zhou YC, Gao F, Zhang ZH,
Xu H, Wang SL and Shen LZ: Aquaporin 3 promotes
epithelial-mesenchymal transition in gastric cancer. J Exp Clin
Cancer Res. 33:382014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu Z, Shen J, Carbrey JM, Mukhopadhyay R,
Agre P and Rosen BP: Arsenite transport by mammalian
aquaglyceroporins AQP7 and AQP9. Proc Natl Acad Sci USA.
99:6053–6058. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bhattacharjee H, Carbrey J, Rosen BP and
Mukhopadhyay R: Drug uptake and pharmacological modulation of drug
sensitivity in leukemia by AQP9. Biochem Biophys Res Commun.
322:836–841. 2004. View Article : Google Scholar : PubMed/NCBI
|
